US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist
  • 3.980
  • -0.180-4.33%
Close Dec 19 16:00 ET
  • 3.790
  • -0.190-4.77%
Post 20:01 ET
253.95MMarket Cap-3.46P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-166.80%-24.55M
-89.93%-13.99M
-37.88%-10.41M
-21.36%-33.46M
-40.03%-9.34M
-56.52%-9.2M
1.62%-7.37M
-0.24%-7.55M
34.52%-27.57M
15.74%-6.67M
Net income from continuing operations
-71.00%-15.5M
-158.51%-21.63M
-124.55%-14.65M
-4.51%-36.95M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
30.18%-35.36M
-3.19%-9.43M
Depreciation and amortization
-2.63%74K
14.47%87K
2.56%80K
-2.20%311K
3.85%81K
-1.30%76K
-6.17%76K
-4.88%78K
-2.45%318K
-11.36%78K
Other non cash items
-557.14%-46K
-59.26%-43K
-79.17%-43K
-78.26%-82K
-33.33%-24K
46.15%-7K
-170.00%-27K
-380.00%-24K
-406.67%-46K
---18K
Change In working capital
-537.85%-9.32M
765.91%7.07M
215.90%2.66M
-250.45%-2.51M
31.29%2.31M
-288.52%-1.46M
-88.97%-1.06M
-660.26%-2.3M
-38.91%1.67M
581.64%1.76M
-Change in prepaid assets
-632.52%-4.48M
-316.86%-1.41M
-173.32%-272K
-422.06%-1.07M
-515.38%-486K
-0.66%-612K
-168.28%-338K
278.37%371K
-106.36%-204K
-89.57%117K
-Change in payables and accrued expense
-464.73%-4.85M
1,285.25%8.44M
210.44%2.95M
-177.36%-1.43M
72.31%2.82M
-162.38%-859K
33.83%-712K
-2,713.68%-2.67M
918.67%1.84M
211.22%1.64M
-Change in other current assets
50.00%15K
450.00%42K
-416.67%-19K
-167.74%-21K
-600.00%-25K
66.67%10K
-163.16%-12K
500.00%6K
112.40%31K
101.27%5K
Cash from discontinued investing activities
Operating cash flow
-166.80%-24.55M
-89.93%-13.99M
-37.88%-10.41M
-21.36%-33.46M
-40.03%-9.34M
-56.52%-9.2M
1.62%-7.37M
-0.24%-7.55M
34.52%-27.57M
15.74%-6.67M
Investing cash flow
Cash flow from continuing investing activities
158.74%27.27M
-545.38%-63.49M
-174.11%-68.36M
136.67%33.35M
94.97%-2.63M
-1,272.04%-46.43M
72.16%-9.84M
92.25M
-476.35%-90.96M
-904.84%-52.23M
Net PPE purchase and sale
---62K
----
----
-64.00%-164K
---164K
--0
----
----
69.97%-100K
--0
Net investment purchase and sale
158.87%27.33M
-542.59%-63.22M
-174.11%-68.36M
136.89%33.52M
95.28%-2.47M
-1,272.04%-46.43M
72.08%-9.84M
--92.25M
-470.83%-90.86M
-903.72%-52.23M
Cash from discontinued investing activities
Investing cash flow
158.74%27.27M
-545.38%-63.49M
-174.11%-68.36M
136.67%33.35M
94.97%-2.63M
-1,272.04%-46.43M
72.16%-9.84M
--92.25M
-476.35%-90.96M
-904.84%-52.23M
Financing cash flow
Cash flow from continuing financing activities
0.00%30K
-334K
162.15M
-99.96%30K
0
30K
0
0
278.46%75.26M
-316K
Net common stock issuance
--0
---345K
--162.15M
--0
--0
--0
--0
--0
278.46%75.26M
---316K
Proceeds from stock option exercised by employees
0.00%30K
----
----
--30K
--0
--30K
----
----
--0
--0
Cash from discontinued financing activities
Financing cash flow
0.00%30K
---334K
--162.15M
-99.96%30K
--0
-99.96%30K
--0
--0
278.46%75.26M
---316K
Net cash flow
Beginning cash position
-64.82%33.65M
-1.24%111.46M
-0.27%28.09M
-60.57%28.16M
-54.16%40.06M
353.90%95.66M
76.62%112.86M
-60.57%28.16M
2.80%71.44M
19.93%87.39M
Current changes in cash
104.96%2.76M
-352.33%-77.81M
-1.56%83.38M
99.82%-76K
79.78%-11.97M
-183.85%-55.6M
59.83%-17.2M
1,224.37%84.7M
-2,320.22%-43.27M
-4,047.20%-59.22M
End cash Position
-9.12%36.41M
-64.82%33.65M
-1.24%111.46M
-0.27%28.09M
-0.27%28.09M
-54.16%40.06M
353.90%95.66M
76.62%112.86M
-60.57%28.16M
-60.57%28.16M
Free cash flow
-167.48%-24.61M
-93.65%-14.26M
-37.88%-10.41M
-21.52%-33.62M
-42.49%-9.51M
-56.52%-9.2M
2.91%-7.37M
-0.24%-7.55M
34.80%-27.67M
15.83%-6.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -166.80%-24.55M-89.93%-13.99M-37.88%-10.41M-21.36%-33.46M-40.03%-9.34M-56.52%-9.2M1.62%-7.37M-0.24%-7.55M34.52%-27.57M15.74%-6.67M
Net income from continuing operations -71.00%-15.5M-158.51%-21.63M-124.55%-14.65M-4.51%-36.95M-37.86%-12.99M-8.94%-9.06M3.47%-8.37M27.03%-6.53M30.18%-35.36M-3.19%-9.43M
Depreciation and amortization -2.63%74K14.47%87K2.56%80K-2.20%311K3.85%81K-1.30%76K-6.17%76K-4.88%78K-2.45%318K-11.36%78K
Other non cash items -557.14%-46K-59.26%-43K-79.17%-43K-78.26%-82K-33.33%-24K46.15%-7K-170.00%-27K-380.00%-24K-406.67%-46K---18K
Change In working capital -537.85%-9.32M765.91%7.07M215.90%2.66M-250.45%-2.51M31.29%2.31M-288.52%-1.46M-88.97%-1.06M-660.26%-2.3M-38.91%1.67M581.64%1.76M
-Change in prepaid assets -632.52%-4.48M-316.86%-1.41M-173.32%-272K-422.06%-1.07M-515.38%-486K-0.66%-612K-168.28%-338K278.37%371K-106.36%-204K-89.57%117K
-Change in payables and accrued expense -464.73%-4.85M1,285.25%8.44M210.44%2.95M-177.36%-1.43M72.31%2.82M-162.38%-859K33.83%-712K-2,713.68%-2.67M918.67%1.84M211.22%1.64M
-Change in other current assets 50.00%15K450.00%42K-416.67%-19K-167.74%-21K-600.00%-25K66.67%10K-163.16%-12K500.00%6K112.40%31K101.27%5K
Cash from discontinued investing activities
Operating cash flow -166.80%-24.55M-89.93%-13.99M-37.88%-10.41M-21.36%-33.46M-40.03%-9.34M-56.52%-9.2M1.62%-7.37M-0.24%-7.55M34.52%-27.57M15.74%-6.67M
Investing cash flow
Cash flow from continuing investing activities 158.74%27.27M-545.38%-63.49M-174.11%-68.36M136.67%33.35M94.97%-2.63M-1,272.04%-46.43M72.16%-9.84M92.25M-476.35%-90.96M-904.84%-52.23M
Net PPE purchase and sale ---62K---------64.00%-164K---164K--0--------69.97%-100K--0
Net investment purchase and sale 158.87%27.33M-542.59%-63.22M-174.11%-68.36M136.89%33.52M95.28%-2.47M-1,272.04%-46.43M72.08%-9.84M--92.25M-470.83%-90.86M-903.72%-52.23M
Cash from discontinued investing activities
Investing cash flow 158.74%27.27M-545.38%-63.49M-174.11%-68.36M136.67%33.35M94.97%-2.63M-1,272.04%-46.43M72.16%-9.84M--92.25M-476.35%-90.96M-904.84%-52.23M
Financing cash flow
Cash flow from continuing financing activities 0.00%30K-334K162.15M-99.96%30K030K00278.46%75.26M-316K
Net common stock issuance --0---345K--162.15M--0--0--0--0--0278.46%75.26M---316K
Proceeds from stock option exercised by employees 0.00%30K----------30K--0--30K----------0--0
Cash from discontinued financing activities
Financing cash flow 0.00%30K---334K--162.15M-99.96%30K--0-99.96%30K--0--0278.46%75.26M---316K
Net cash flow
Beginning cash position -64.82%33.65M-1.24%111.46M-0.27%28.09M-60.57%28.16M-54.16%40.06M353.90%95.66M76.62%112.86M-60.57%28.16M2.80%71.44M19.93%87.39M
Current changes in cash 104.96%2.76M-352.33%-77.81M-1.56%83.38M99.82%-76K79.78%-11.97M-183.85%-55.6M59.83%-17.2M1,224.37%84.7M-2,320.22%-43.27M-4,047.20%-59.22M
End cash Position -9.12%36.41M-64.82%33.65M-1.24%111.46M-0.27%28.09M-0.27%28.09M-54.16%40.06M353.90%95.66M76.62%112.86M-60.57%28.16M-60.57%28.16M
Free cash flow -167.48%-24.61M-93.65%-14.26M-37.88%-10.41M-21.52%-33.62M-42.49%-9.51M-56.52%-9.2M2.91%-7.37M-0.24%-7.55M34.80%-27.67M15.83%-6.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+3.16%
Teradata Corp
TDC
+1.90%
Collegium Pharmaceutical
COLL
+1.40%
Halozyme Therapeutics
HALO
+1.02%
Hutchmed (China)
HCM
+0.90%

Unlock the Full List